Price T Rowe Associates Inc Vanda Pharmaceuticals Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 18,895 shares of VNDA stock, worth $95,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,895
Previous 17,030
10.95%
Holding current value
$95,419
Previous $97,000
8.25%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VNDA
# of Institutions
161Shares Held
45.2MCall Options Held
165KPut Options Held
33.6K-
Black Rock Inc. New York, NY8.14MShares$41.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.01MShares$20.3 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$18.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$11.9 Million0.94% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$11.4 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $286M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...